Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC

Published Date: 13 Sep 2024

However, plinabulin plus docetaxel still "not ready for prime time," expert says

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy

2.

New research uncovers link between cancer pathway and blood-retina barrier function

3.

In Resectable Lung Cancer, Perioperative Nivolumab Increases EFS.

4.

A consensus statement from researchers on the proper use of Lu-177 PSMA-617 radionuclide therapy and patient selection is published.

5.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot